Signal Detection & Management · Section 7.6
~6 min read · The Drug Safety Coach — Global PV Career Course
Key points
Full text
Everything covered so far in this module — disproportionality metrics, confidence intervals, Bayesian shrinkage — produces a statistical flag: a drug-event pair that has crossed a numeric threshold. That flag is not yet a validated signal, and the distinction matters enormously. A statistical flag is the mechanical output of a formula applied to reporting data; a validated signal is the product of a qualified medical reviewer examining that flag and judging that it genuinely warrants further investigation.
Validation review works through a specific set of questions a formula can’t answer on its own. Is there biological plausibility — does the drug’s known pharmacology offer a credible mechanism for this event? Is the clinical picture consistent across the individual cases contributing to the flag, or does "the same event" actually represent several different, loosely related clinical presentations lumped together by MedDRA coding? Could the elevated reporting be explained by confounding by indication — where the drug is disproportionately prescribed to patients who already carry elevated risk of the event for reasons unrelated to the drug — or by concomitant medications, or by the underlying disease’s natural progression rather than the drug itself?
A statistical flag that fails this review isn’t a wasted step in the pipeline — documenting the reviewer’s reasoning for why a flag was not validated is itself part of the formal signal management record, and it matters for exactly the reason case-level documentation matters throughout this course: a regulator or auditor reviewing the signal management process later needs to see not just which flags were escalated, but the reasoning behind the ones that weren’t.
This human review step is precisely the point in the pipeline that GVP Module IX and, later in this module, CIOMS Working Group XIV both insist cannot be delegated entirely to automation. A statistical algorithm can surface candidates efficiently at a scale no human team could match manually — but biological plausibility, confounding assessment, and clinical judgment about whether a pattern is medically coherent remain distinctly human tasks, which is exactly the boundary Lesson 7.10 explores in more depth.
Important
Validation is where "statistically elevated" and "medically meaningful" get reconciled — and they don’t always agree. A pair can be statistically elevated because of confounding by indication (the drug is disproportionately given to patients who already have elevated risk of the event, independent of the drug itself) rather than because the drug actually causes the event. Catching that distinction is exactly the job of the human reviewer at this step.
Quick check
Test yourself before moving on — no pressure, just click an answer.
1. What is "confounding by indication," and why does it matter during signal validation?